Tonix Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement

    NEXT STORY
    Apollomics, Inc. Announces Successful Enrollment of First Patient Into Phase 1 Clinical Trial of APL-106 (Uproleselan Injection) in China
    PREV STORY
    Sotherly Hotels Inc. Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2020
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    AIR Experts to Present at the 22nd Annual Conference on Advancing School Mental Health

    Washington, D.C, Oct. 19, 2017 (GLOBE NEWSWIRE) -- American Institutes for Research (AIR) experts ...

    author_avatar
    NASDAQ Market News

    American BriVision Announces Issuance of a Full Clinical Study Report (CSR) for ABV-1504 for Major Depressive Disorder Phase II Study

    author_avatar
    NASDAQ Market News

    Amarin and Mochida Announce Collaboration on Future Development of EPA-based Drug Products and Indications

    BEDMINSTER, N.J. and DUBLIN, Ireland, June 12, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc ...

    author_avatar
    NASDAQ Market News